ArticleTherapeutic innovation & regulatory science2025
Subsequent Indications in Oncology Drugs: Pathways, Timelines, and the Inflation Reduction Act.
Julie A Patterson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it